Partners Group embraces AI to drive growth in FairJourney Biologics

The firm agreed to buy a majority stake in FairJourney, valued at around €900m, in early July.

22 July 2024•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.